Lv41
440 积分 2026-03-27 加入
GPR119 agonists for type 2 diabetes: past failures and future hopes for preclinical and early phase candidates
2个月前
已完结
Discovery of MKP10241, a Novel Small Molecule Targeting the GPR119/Incretin Axis to Treat Metabolic Disorders
2个月前
已完结
Pharmacological Profile of NCP-322, a Novel G Protein-Coupled Receptor 119 Agonist, as an Orally Active Therapeutic Agent for Type 2 Diabetes Mellitus
2个月前
已完结
Structural identification of lysophosphatidylcholines as activating ligands for orphan receptor GPR119
2个月前
已完结
GLP-1R agonists for the treatment of obesity: a patent review (2015-present)
2个月前
已完结
An updated patent review of GLP-1 receptor agonists (2020-present)
2个月前
已完结
New Efficient Method for the Total Synthesis of (S,S)-Isodityrosine from Natural Amino Acids
3个月前
已完结
Discovery of Selenium-Containing Derivatives as Potent and Orally Bioavailable GLP-1R Agonists
4个月前
已完结
An Insight into Pharmaceutical Design and Pharmacokinetic Characteristics of GLP-1 RAs
6个月前
已完结
皖公网安备34019202002308
